However, the effects of Rituximab waned after 18 months, likely due to the need for repeated dosing, and both agents carry an inherent risk of systemic immunosuppression and opportunistic infections [136, 137]
Influence of overweight and obesity on circulating inflammation-related microRNA
Pediatric Dosing Recommended dosage for children may vary based on different medical conditions: For the initial treatment of pernicious anemia, the usual dose is 30-50mcg SC/IM, given every day for 2 weeks, followed by maintenance treatment
This is general educational information, not a personal administration protocol
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes
Zheng G, Huang L, Tong H, Shu Q, Hu Y, Ge M, et al